“A Review of the Genetic Variants Affecting Efficacy and Adverse Effects of Standard of Care Treatment in Patients with Chronic Myelogenous Leukemia” (2022) Precision Medicine Communications, 2(1), pp. 43–58. doi:10.55627/pmc.002.01.0045.